Indegene Secures Preliminary Court Approval for $4.72M

Indegene Limited’s U.S. subsidiary has received preliminary approval from the U.S. District Court (District of New Jersey) to settle a multi-year class-action lawsuit regarding alleged violations of the Telephone Consumer Protection Act (unsolicited fax communications in 2020). Key Highlights: Capped Liability: The maximum settlement fund is capped at USD 4.72 million on a claims-made basis ($250 per eligible claim). Reversionary Structure: Unclaimed funds will revert to the defendants, meaning the actual cash outflow is highly likely to be significantly lower than the maximum cap. Timeline: The claims submission deadline is December 9, 2026, with a final fairness hearing scheduled for January 12, 2027. Strategic & Financial Impact: Negligible Financial Hit: With robust cash reserves and current investments exceeding ₹1,481 crore, this bounded liability will have no material impact on Indegene’s balance sheet or capital allocation plans. Risk Removal: The preliminary approval successfully rings-fences a legacy legal overhang, transitioning the matter from active litigation to a controlled, predictable resolution. Market Outlook: This development is expected to be neutral to mildly positive for the stock. By eliminating a source of non-systemic uncertainty and bounding the financial exposure, Indegene removes a key distraction, allowing management and investors to remain fully focused on the company’s core business growth and expansion strategies.